Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 1
2010 1
2011 1
2012 1
2013 1
2014 2
2015 3
2016 2
2018 2
2019 4
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Pulmonary sarcoidosis.
Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Spagnolo P, et al. Lancet Respir Med. 2018 May;6(5):389-402. doi: 10.1016/S2213-2600(18)30064-X. Epub 2018 Apr 3. Lancet Respir Med. 2018. PMID: 29625772 Review.
The severity of pulmonary sarcoidosis ranges from incidentally discovered radiographic abnormalities in asymptomatic patients to a chronic progressive disease that is refractory to treatment. Mortality from sarcoidosis appears to have increased in the past three decades, w …
The severity of pulmonary sarcoidosis ranges from incidentally discovered radiographic abnormalities in asymptomatic patients to a chroni
Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?
Hayes GE, Novak-Frazer L. Hayes GE, et al. J Fungi (Basel). 2016 Jun 7;2(2):18. doi: 10.3390/jof2020018. J Fungi (Basel). 2016. PMID: 29376935 Free PMC article. Review.
Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million people worldwide making it an under recognised, but significant health problem across the globe, conferring significant morbidity and mortality. ...When a fungal ball/aspergilloma is visible radi
Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million people worldwide making it an under recognised, but sig
Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).
Al-Shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW. Al-Shair K, et al. Respir Med. 2016 May;114:117-22. doi: 10.1016/j.rmed.2016.03.020. Epub 2016 Apr 2. Respir Med. 2016. PMID: 27109821 Free article.
INTRODUCTION: Fatigue is a prominent disabling symptom in several pulmonary diseases. Its impact on health status in patients with chronic pulmonary aspergillosis (CPA) has not been investigated. METHODS: A total of 151 CPA patients attending the National …
INTRODUCTION: Fatigue is a prominent disabling symptom in several pulmonary diseases. Its impact on health status in patients with …
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).
Setianingrum F, Rozaliyani A, Adawiyah R, Syam R, Tugiran M, Sari CYI, Nandipinto F, Ramnath J, Arifin AR, Handayani D, Burhan E, Rumende M, Wahyuningsih R, Rautemaa-Richardson R, Denning DW. Setianingrum F, et al. Thorax. 2021 Nov 30:thoraxjnl-2020-216464. doi: 10.1136/thoraxjnl-2020-216464. Online ahead of print. Thorax. 2021. PMID: 34848556 Free article.
OBJECTIVES: Chronic pulmonary aspergillosis (CPA) can complicate recovery from pulmonary TB. ...Diabetes mellitus was a significant risk factor for CPA (p=0.040). Persistent cough (n=5, 50%; p=0.005) and fatigue (n=6, 60%; p=0.001) were the most common sympto …
OBJECTIVES: Chronic pulmonary aspergillosis (CPA) can complicate recovery from pulmonary TB. ...Diabetes mellitus was a signif …
Chronic Nodular Pulmonary Aspergillosis in a Patient with Rheumatoid Arthritis.
Ito Y, Tanigawa M, Takemura T, Iwamoto K, Nigi A, Sasano H, Itani H, Kondo S, Tokui T, Nakamura S, Miyazaki Y. Ito Y, et al. Intern Med. 2019;58(7):979-984. doi: 10.2169/internalmedicine.1918-18. Epub 2019 Apr 1. Intern Med. 2019. PMID: 30930349 Free PMC article.
Chronic pulmonary aspergillosis, which features nodular lesions known as Aspergillus nodules, is a relatively uncommon disorder. We herein report a case of slowly progressing chronic multiple nodular pulmonary aspergillosis in a 59-year-old man with rh
Chronic pulmonary aspergillosis, which features nodular lesions known as Aspergillus nodules, is a relatively uncommon disorde
Chronic Pulmonary Aspergillosis and Type 2 Diabetes Mellitus Complicating Granulomatosis with Polyangiitis in an Adult Saudi Male: A Case Report.
Eldaabossi S, Saad M, Alabdullah M, Awad A, Alquraini H, Moumneh G, Mansour A. Eldaabossi S, et al. Int Med Case Rep J. 2021 Dec 20;14:829-837. doi: 10.2147/IMCRJ.S340231. eCollection 2021. Int Med Case Rep J. 2021. PMID: 34984031 Free PMC article.
BACKGROUND: Granulomatosis with polyangiitis (GPA) is an extremely rare autoimmune, necrotizing granulomatous disease of unknown etiology affecting small and medium-sized blood vessels. Chronic pulmonary aspergillosis (CPA) is a rare fungal infection with high morbi …
BACKGROUND: Granulomatosis with polyangiitis (GPA) is an extremely rare autoimmune, necrotizing granulomatous disease of unknown etiology af …
Chronic Fatigue Syndrome and Bone Marrow Defects of the Jaw - A Case Report on Additional Dental X-Ray Diagnostics with Ultrasound.
Lechner J, Schick F. Lechner J, et al. Int Med Case Rep J. 2021 Apr 19;14:241-249. doi: 10.2147/IMCRJ.S306641. eCollection 2021. Int Med Case Rep J. 2021. PMID: 33907473 Free PMC article.
PATIENTS AND METHODS: A case of chronic fatigue syndrome (CFS) in a young man presenting the typical, ambiguous symptoms, which were accompanied by headaches and tinnitus. ...CONCLUSION: In contrast to radiography, complementary TAU imaging of the BMDJ revealed c
PATIENTS AND METHODS: A case of chronic fatigue syndrome (CFS) in a young man presenting the typical, ambiguous symptoms, whic …
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
Kosmidis C, Rodriguez-Goncer I, Rautemaa-Richardson R, Richardson MD, Moore CB, Denning DW. Kosmidis C, et al. J Antimicrob Chemother. 2019 Apr 1;74(4):1056-1061. doi: 10.1093/jac/dky539. J Antimicrob Chemother. 2019. PMID: 30590533
BACKGROUND: Posaconazole delayed-release tablets offer better bioavailability than the liquid suspension, but no post-marketing data are available in immunocompetent hosts such as those with chronic pulmonary aspergillosis (CPA). OBJECTIVES: To explore the pharmacok …
BACKGROUND: Posaconazole delayed-release tablets offer better bioavailability than the liquid suspension, but no post-marketing data are ava …
Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.
Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Denning DW, et al. Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S265-80. doi: 10.1086/376526. Clin Infect Dis. 2003. PMID: 12975754
We describe 18 nonimmunocompromised patients with chronic pulmonary aspergillosis. Duration of the disease ranged from several months to >12 years. All 18 patients had prior pulmonary disease. Weight loss, chronic cough (often with hemoptysis and shortness …
We describe 18 nonimmunocompromised patients with chronic pulmonary aspergillosis. Duration of the disease ranged from several …
Pulmonary tuberculosis in an immunocompetent patient with primary laryngeal aspergillosis.
Sarkar NK, Gope BP. Sarkar NK, et al. Respirol Case Rep. 2020 May 17;8(5):e00586. doi: 10.1002/rcr2.586. eCollection 2020 Jul. Respirol Case Rep. 2020. PMID: 32431816 Free PMC article.
Primary laryngeal aspergillosis in an immunocompetent host is a rare entity. On the other hand, pulmonary tuberculosis (PTB) among healthcare workers in a tuberculosis endemic zone with high risk of exposure is not uncommon but may be underdiagnosed especially when masquer …
Primary laryngeal aspergillosis in an immunocompetent host is a rare entity. On the other hand, pulmonary tuberculosis (PTB) among he …
23 results